Ralph Laufer

Ralph Laufer

Company: Lysogene

Job title: Chief Scientific Officer

Seminars:

Q&A Panel Discussion: Intra-CSF Delivery – Moving from Paediatric to Adult Patient Populations 9:15 am

Read more

day: Day Two

Intracisternal Delivery to the CNS of an AAV Gene Therapy Candidate for the Treatment of GM1 Gangliosidosis 8:40 am

Routes of delivery of AAV vectors to the CNS Intracisternal (ICM) administration: bioavailability and safety considerations Preclinical evaluation of ICM-administered AAVrh10 vector carrying human GLB1 Status of clinical trial in GM1 gangliosidosis patientsRead more

day: Day One

Q&A Panel Discussion: Highlighting Key Clinical Progress in Gene Therapies for Neurological Disorders 9:20 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.